SVB Financial Group (SIVB) Prices 2.27M Share Offering at $564/sh

SVB Financial Group ("SVB") (NASDAQ: SIVB), announced today the pricing of its underwritten public offering of 2,227,000 shares of its common stock at a price to the public of $564.00 per share for expected gross proceeds of approximately $1.25 billion before underwriting discounts and commissions and offering expenses. SVB has also granted the underwriter an option to purchase up to an additional 334,000 shares of its common stock. SVB intends to use the net proceeds from the offering for general corporate purposes, including supporting capital ratios at SVB and its subsidiary bank, Silicon Valley Bank.

Goldman Sachs & Co. LLC is acting as book-running manager for the offering.

The offering is expected to close on Aug. 12, 2021, subject to the satisfaction of customary closing conditions.

The offering is being made pursuant to an effective shelf registration statement, including a prospectus and prospectus supplement, filed by SVB with the U.S. Securities and Exchange Commission ("SEC"). Investors should read the prospectus in that registration statement, the related prospectus supplement and other documents SVB has filed with the SEC for more complete information about SVB and the offering before investing. These documents may be obtained for free by visiting the SEC website at www.sec.gov. Alternatively, SVB, the underwriter or any dealer participating in the offering will arrange to send you the prospectus contained in the registration statement, together with the related prospectus supplement, if you request it by contacting Goldman Sachs & Co. LLC at 200 West Street, New York, NY 10282, Attention: Prospectus Department, telephone: 1-866-471-2526, facsimile: 212-902-9316 or by emailing [email protected]. This press release is for informational purposes only and does not constitute an offer to sell, or a solicitation of an offer to buy, these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

You May Also Be Interested In

• Matinas BioPharma to merge with GH Power, sell drug unit to Azurity
• Banzai prices $0.9M public offering at $2.75 per share
• CoStar Group names Robin Rossmann as CFO, effective July 2026